Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kassiou

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 4, 2011
Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agentIman A Moussa, Samuel D Banister, Nicolas Giboureau, et al.
Chemical Communications (Cambridge, England)|October 14, 2011
Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cellsEllen L Crossley, Fatiah Issa, Alana M Scarf, et al.
European Journal of Medicinal Chemistry|July 19, 2019
Strategies to develop selective CB<sub>2</sub> receptor agonists from indole carboxamide synthetic cannabinoidsMichael Moir, Samuel Lane, Felcia Lai, et al.
European Journal of Medicinal Chemistry|December 15, 2020
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonistMichael Moir, Samuel Lane, Andrew P Montgomery, et al.
Bioorganic & Medicinal Chemistry|August 29, 2013
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effectsSamuel D Banister, Miral Manoli, Melissa L Barron, et al.
Pharmacology Research & Perspectives|February 27, 2020
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonistsShivani Sachdev, Samuel D Banister, Marina Santiago, et al.
ACS Chemical Neuroscience|August 4, 2012
Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatumKatherine R Leaver, Aaron Reynolds, Sylvie Bodard, et al.
Plos One|May 6, 2022
Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variantPrita R Asih, Anne Poljak, Michael Kassiou, et al.
European Journal of Medicinal Chemistry|April 9, 2026
Erratum to 'The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist' [Eur. J. Med. Chem. 210 (2021) 113087]Michael Moir, Samuel Lane, Andrew P Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2022
Strategies for targeting the P2Y<sub>12</sub> receptor in the central nervous systemBen B Ma, Andrew P Montgomery, Biling Chen, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry Letters|October 4, 2011
Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agentIman A Moussa, Samuel D Banister, Nicolas Giboureau, et al.
Chemical Communications (Cambridge, England)|October 14, 2011
Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cellsEllen L Crossley, Fatiah Issa, Alana M Scarf, et al.
European Journal of Medicinal Chemistry|July 19, 2019
Strategies to develop selective CB<sub>2</sub> receptor agonists from indole carboxamide synthetic cannabinoidsMichael Moir, Samuel Lane, Felcia Lai, et al.
European Journal of Medicinal Chemistry|December 15, 2020
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonistMichael Moir, Samuel Lane, Andrew P Montgomery, et al.
Bioorganic & Medicinal Chemistry|August 29, 2013
N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as σ receptor ligands with potential neuroprotective effectsSamuel D Banister, Miral Manoli, Melissa L Barron, et al.
Pharmacology Research & Perspectives|February 27, 2020
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonistsShivani Sachdev, Samuel D Banister, Marina Santiago, et al.
ACS Chemical Neuroscience|August 4, 2012
Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatumKatherine R Leaver, Aaron Reynolds, Sylvie Bodard, et al.
Plos One|May 6, 2022
Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variantPrita R Asih, Anne Poljak, Michael Kassiou, et al.
European Journal of Medicinal Chemistry|April 9, 2026
Erratum to 'The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist' [Eur. J. Med. Chem. 210 (2021) 113087]Michael Moir, Samuel Lane, Andrew P Montgomery, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2022
Strategies for targeting the P2Y<sub>12</sub> receptor in the central nervous systemBen B Ma, Andrew P Montgomery, Biling Chen, et al.
Pageof 24